PATENT CLAIM ANALYSIS

Application Number: 16048125
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["558", "070000"]

Abstract:
The present invention provides novel bisphosphonate conjugates, pharmaceutical compositions comprising bisphosphonate conjugates and methods of using such analogs in the treatment of bone cancer, bone-related diseases, bone infection, bone inflammation, and diseases of the soft tissues surrounding bones.

Claim (Index 8):
A pharmaceutical composition comprising a conjugate of  claim 1  and a pharmaceutically-acceptable carrier.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 1.41935
- Patent Class: 558.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14968481', '14063951', '10742453', '12413805', '09833083']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7193814561262359
- 35 USC 102 Novelty (BERT): 0.5593807402040776
- Combined Prediction Score: 0.7033813845340201
- Mean Citation Score: 346.898196
- Max Citation Score: 380.09067000000016
- Similarity Product: 377.53620903310434

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test